Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Colitis, Ulcerative × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 29 Advanced Solid Tumor 21 Advanced Solid Tumors 19 Carcinoma, Non-Small-Cell Lung 15 Neoplasms 13 Solid Tumor 11 Prostatic Neoplasms 10 Multiple Myeloma 10 Recurrence 9 Pancreatic Neoplasms 9 Lung Neoplasms 9 Neoplasm Metastasis 8 Lymphoma, Large B-Cell, Diffuse 8 Stomach Neoplasms 7 Small Cell Lung Carcinoma 7 Ovarian Neoplasms 7 Leukemia, Myeloid, Acute 7 Carcinoma, Hepatocellular 7 Melanoma 6 Triple Negative Breast Neoplasms 5 Solid Tumors 5 Sarcoma 5 Colorectal Neoplasms 5 Carcinoma, Transitional Cell 5 Advanced Solid Tumour 5 Uterine Cervical Neoplasms 4 Myelodysplastic Syndromes 4 Head and Neck Neoplasms 4 Biliary Tract Neoplasms 4 Advanced Malignant Solid Tumor 4

Interventions

etrolizumab 4 Infliximab 3 peficitinib 1 golimumab 1 NX-13 1 Methylprednisolone 1 Mesalamine 1 Injections 1 CT-P13 1 Andrographis paniculata extract 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02136069 2021-12-03

GARDENIA

Hoffmann-La Roche

Phase 3 Completed

397 enrolled 32 charts

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡